We bring forward the most recent studies, research, and data related to atopic diseases in the eczema world, and latest technologies relevant to help you manage your eczema. The collective responses from the research papers, studies, and community have been summarized in the posts to help you evaluate the findings and use your judgment making decisions about your condition.
Dupilumab approval by FDA US Food and Drug Administration has paved the way for several adults with moderate to severe eczema. Dupixent (dupilumab) injection from the drugmakers, Sanofi – a French pharma industry and Regeneron Pharmaceuticals – a US biotech […]
